Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2001-1-11
pubmed:abstractText
Vascular endothelial-cadherin (VE-cad) is an endothelial cell-specific adhesion molecule that is crucial for proper assembly of vascular tubes. Here we show that a monoclonal antibody (BV13) directed to the extracellular region of VE-cad inhibits formation of adherens junctions and capillary-like structures by endothelial cells and blocks angiogenesis in the mouse cornea and in Matrigel plugs in vivo. Systemic administration of BV13 markedly decreases the growth of s.c. Lewis lung or human A431 epidermoid tumors and strongly suppresses the growth of Lewis lung metastases. These data demonstrate that VE-cad is essential for postnatal angiogenesis and thus validate VE-cad as a novel target for antiangiogenesis agents.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31, http://linkedlifedata.com/resource/pubmed/chemical/Cadherins, http://linkedlifedata.com/resource/pubmed/chemical/Collagen, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Laminin, http://linkedlifedata.com/resource/pubmed/chemical/Proliferating Cell Nuclear Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Proteoglycans, http://linkedlifedata.com/resource/pubmed/chemical/cadherin 5, http://linkedlifedata.com/resource/pubmed/chemical/matrigel
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6805-10
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11156369-Animals, pubmed-meshheading:11156369-Antibodies, Monoclonal, pubmed-meshheading:11156369-Antigens, CD, pubmed-meshheading:11156369-Antigens, CD31, pubmed-meshheading:11156369-Cadherins, pubmed-meshheading:11156369-Carcinoma, Lewis Lung, pubmed-meshheading:11156369-Cell Adhesion, pubmed-meshheading:11156369-Cell Division, pubmed-meshheading:11156369-Collagen, pubmed-meshheading:11156369-Cornea, pubmed-meshheading:11156369-Dose-Response Relationship, Drug, pubmed-meshheading:11156369-Drug Combinations, pubmed-meshheading:11156369-Endothelium, pubmed-meshheading:11156369-Humans, pubmed-meshheading:11156369-Immunoglobulin G, pubmed-meshheading:11156369-Immunohistochemistry, pubmed-meshheading:11156369-In Situ Nick-End Labeling, pubmed-meshheading:11156369-Laminin, pubmed-meshheading:11156369-Lung Neoplasms, pubmed-meshheading:11156369-Mice, pubmed-meshheading:11156369-Mice, Nude, pubmed-meshheading:11156369-Neoplasm Metastasis, pubmed-meshheading:11156369-Neoplasm Transplantation, pubmed-meshheading:11156369-Neovascularization, Pathologic, pubmed-meshheading:11156369-Neovascularization, Physiologic, pubmed-meshheading:11156369-Proliferating Cell Nuclear Antigen, pubmed-meshheading:11156369-Proteoglycans, pubmed-meshheading:11156369-Time Factors, pubmed-meshheading:11156369-Tumor Cells, Cultured
pubmed:year
2000
pubmed:articleTitle
Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.
pubmed:affiliation
Department of Immunology, ImClone Systems Incorporated, New York, New York 10014, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.